With FFAR4/ligand presence in breast cancer tissues confirmed, we next compared RFS and BCSS between FFAR4-high and FFAR4-low patients in the exploration cohort (n = 307) collected from 2 independent institutions. This evidence concerns the gene FFAR4 and breast cancer.